Shares of Henry Schein HSIC decreased 3.0% in pre-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share increased 31.91% over the past year to $1.24, which beat the estimate of $0.85.
Revenue of $2,925,000,000 up by 20.42% year over year, which beat the estimate of $2,810,000,000.
Looking Ahead
Henry Schein hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: May 04, 2021
Time: 10:00 AM
ET Webcast URL: https://investor.henryschein.com/presentations?c=74322&p=irol-presentations
Recent Stock Performance
52-week high: $74.89
52-week low: $49.83
Price action over last quarter: Up 11.17%
Company Profile
Henry Schein is the largest wholesaler of dental and medical products to office-based practitioners. The company has been established for approximately 90 years and operates across nearly 30 distribution centers to offer hundreds of thousands of products to customers globally. Henry Schein also offers practice management products that include software products, technical, financial, and educational services. The company recently spun off its animal health business.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
